首页> 外文期刊>Lifetime Data Analysis >Two-sample tests for survival data from observational studies
【24h】

Two-sample tests for survival data from observational studies

机译:来自观察性研究的生存数据的两样本检验

获取原文
获取原文并翻译 | 示例
       

摘要

When observational data are used to compare treatment-specific survivals, regular two-sample tests, such as the log-rank test, need to be adjusted for the imbalance between treatments with respect to baseline covariate distributions. Besides, the standard assumption that survival time and censoring time are conditionally independent given the treatment, required for the regular two-sample tests, may not be realistic in observational studies. Moreover, treatment-specific hazards are often non-proportional, resulting in small power for the log-rank test. In this paper, we propose a set of adjusted weighted log-rank tests and their supremum versions by inverse probability of treatment and censoring weighting to compare treatment-specific survivals based on data from observational studies. These tests are proven to be asymptotically correct. Simulation studies show that with realistic sample sizes and censoring rates, the proposed tests have the desired Type I error probabilities and are more powerful than the adjusted log-rank test when the treatment-specific hazards differ in non-proportional ways. A real data example illustrates the practical utility of the new methods.
机译:当使用观察数据比较特定治疗的生存率时,需要针对常规协变量分布,针对治疗之间的不平衡调整常规的两样本检验,例如对数秩检验。此外,标准的假定生存时间和检查时间在条件上独立的标准假设在观察研究中可能是不现实的,而这种治疗是常规两样本测试所需的。此外,特定于治疗的危害通常是不成比例的,因此对数秩检验的功效较小。在本文中,我们根据观察研究的数据,通过治疗的逆概率和审查权重提出了一组调整后的加权对数秩检验及其最高版本,以比较特定治疗的生存期。这些测试被证明是渐近正确的。仿真研究表明,通过实际的样本量和检查率,所提出的测试具有所需的I型错误概率,并且当特定于治疗的危害以非比例方式变化时,其比调整后的对数秩检验更有效。一个真实的数据示例说明了新方法的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号